Swiss Group for Clinical Cancer Research clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 106 studies whose lead sponsor is Swiss Group for Clinical Cancer Research. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 6, 2025.
Focus areas
Conditions Swiss Group for Clinical Cancer Research leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 106. Browse all 106 →
- Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell CarcinomaCompletedNCT03297593Phase 2
- Adjuvant Aspirin Treatment for Colon Cancer PatientsTerminatedNCT02467582Phase 3
- Therapy De-escalation in Seminoma Stage IIA/BTerminatedNCT01593241Phase 2
- TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid TumorsTerminatedNCT03387917Phase 1
- Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After SurgeryCompletedNCT01272050Phase 3
- Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPCTerminatedNCT04629781Phase 1
- SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph IICompletedNCT04480372Phase 2
- ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.TerminatedNCT02933801Phase 2
- Rituximab With or Without Ibrutinib for Patients With Advanced Follicular LymphomaTerminatedNCT02451111Phase 2
- Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC PatientsCompletedNCT00030771Phase 3
- CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast CancerTerminatedNCT02067741Phase 2
- Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide AloneTerminatedNCT02640534Phase 2
- Activity Program During Aromatase Inhibitor TherapyCompletedNCT03786198Not applicable
- Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular LymphomaTerminatedNCT01307605Phase 2
- Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2TerminatedNCT00004935Phase 3
- VPM1002BC in Recurrent Non-muscle Invasive Bladder CancerCompletedNCT02371447Phase 1/2
- Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate CancerTerminatedNCT03921996Phase 3
- Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal CancerTerminatedNCT02910843Phase 1
- Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)TerminatedNCT03762122Phase 2
- Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line ChemotherapyTerminatedNCT02597075Not applicable
- NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaTerminatedNCT03524898Phase 1/2
- Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple MyelomaTerminatedNCT01555281Phase 1/2
- Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma PatientsCompletedNCT02877550Phase 1
- Prostate Cancer BiobankActive, not recruitingNCT04024475
- SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After ProstatectomyTerminatedNCT02945813Phase 2
- Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.TerminatedNCT03886649Phase 1
- Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell LymphomaTerminatedNCT02356458Phase 1/2
- Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01059188Phase 2
- Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast CancerTerminatedNCT02833766Phase 2
- Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast CancerTerminatedNCT02404506Phase 2
- Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.CompletedNCT02964689Phase 1
- Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.CompletedNCT03213301Phase 2
- Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple MyelomaTerminatedNCT03520985Phase 2
- Trastuzumab & Pertuzumab Followed by T-DM1 in MBCCompletedNCT01835236Phase 2
- Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT01107639Phase 3
- Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal CancerTerminatedNCT00544700Phase 3
- Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLCCompletedNCT02058056Not applicable
- LDE225 and Paclitaxel in Solid TumorsCompletedNCT01954355Phase 1
- Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate CancerCompletedNCT01243385Phase 2
- Everolimus as First-Line Therapy in Treating Patients With Prostate CancerCompletedNCT00976755Phase 2
- Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00006023Phase 2
- Vinorelbine in Treating Patients With Metastatic Prostate CancerCompletedNCT00003259Phase 2
- Biological Therapy in Treating Patients With Bladder CancerCompletedNCT00003779Phase 3
- Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00004187Phase 1/2
- Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive MyelomaCompletedNCT02188537Phase 2
- Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal TumorsCompletedNCT00568750Phase 2
- Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00392691Phase 1
- Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00334594Phase 2
- Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung CancerCompletedNCT00003231Phase 2
- Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell LymphomaCompletedNCT00003280Phase 3